This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Pediatrics  • Adolescent Medicine  • Immunization  • Tobacco  • Quality of Care  • Patient Safety/ Medical Error  • Drug Therapy  • Adverse Effects  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2008;300(23):2713-2714.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

All smokers should receive the pneumococcal vaccine, advisors to the US Centers for Disease Control and Prevention (CDC) recommended in October. It is the first time smokers have ever been targeted for vaccination.

The CDC's Advisory Committee on Immunization Practices recommended that all smokers aged 19 years through 64 years be vaccinated with the 23-valent pneumococcal polysaccharide vaccine. Additionally, the panel urged that physicians offer cessation therapies along with the vaccine. Typically, the CDC follows the committee's recommendations.

Panel members also received an update on efforts by the CDC and the US Food and Drug Administration (FDA) to monitor the postmarketing safety of the human papillomavirus vaccine (HPV), which was first recommended for preteen girls in 2006. The agencies' report suggested there is no increased risk of serious adverse events associated with the vaccine.

Health officials recommend that all smokers be immunized to prevent pneumococcal disease. (Photo . . . [Full Text of this Article]

SMOKING AND INFECTION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?